Withdrawn identifier

`XF-07BCVRH-5`

This identifier is permanent and will always resolve. It is no longer listed in the registry.

Not an extra-financial disclosure. This document is not an extra-financial disclosure (it is press coverage or other supporting material) and is therefore not listed in the registry.

Recorded as: Amgen Response in Support of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias | Amgen
Type: PRESS
Issuer: Amgen Inc.
Year: 2019
Source: https://www.amgen.com/newsroom/company-statements/amgen-response-in-support-of-the-2019-es

Search the registry

Status as of 2026-08-30. Machine-readable at /api/registry/XF07BCVRH5.
Identifiers published by XframeworkID are never withdrawn from resolution — if a record is found to be an error, a duplicate, or is superseded, this page explains what happened to it.